Business Q&A: Karl Bergman, CEO of Elypta

The days of Swedish liquid biopsy startup Elypta are hectic – the company has won prestigious awards and grants, and they will soon initiate the largest study in the world within kidney cancer diagnostics. The company’s method involves measuring a unique panel of metabolites whose composition has been found to be altered in the blood … Continue reading Business Q&A: Karl Bergman, CEO of Elypta